Protagonist Therapeutics, Inc.
Clinical trials sponsored by Protagonist Therapeutics, Inc., explained in plain language.
Protagonist Therapeutics, Inc.
PTGX
NASDAQ
A biopharmaceutical company developing peptide-based therapies for gastrointestinal and blood disorders.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.